These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28532374)

  • 1. What Does Genetics Tell Us About Age-Related Macular Degeneration?
    Grassmann F; Ach T; Brandl C; Heid IM; Weber BHF
    Annu Rev Vis Sci; 2015 Nov; 1():73-96. PubMed ID: 28532374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?
    Grassmann F; Fauser S; Weber BH
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):194-202. PubMed ID: 25986585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.
    Gehrs KM; Anderson DH; Johnson LV; Hageman GS
    Ann Med; 2006; 38(7):450-71. PubMed ID: 17101537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of age-related macular degeneration and therapeutic opportunities.
    van Lookeren Campagne M; LeCouter J; Yaspan BL; Ye W
    J Pathol; 2014 Jan; 232(2):151-64. PubMed ID: 24105633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapeutic developments in atrophic age-related macular degeneration.
    Hanus J; Zhao F; Wang S
    Br J Ophthalmol; 2016 Jan; 100(1):122-7. PubMed ID: 26553922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
    Li H; Chintalapudi SR; Jablonski MM
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1103-1114. PubMed ID: 28816076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Therapies for Age-related Macular Degeneration: The Art and Science of Problem-solving: The 2018 Charles L. Schepens, MD, Lecture.
    Miller JW
    Ophthalmol Retina; 2019 Oct; 3(10):900-909. PubMed ID: 31585712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related macular degeneration in Onitsha, Nigeria.
    Nwosu SN
    Niger J Clin Pract; 2011; 14(3):327-31. PubMed ID: 22037079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential DNA methylation identified in the blood and retina of AMD patients.
    Oliver VF; Jaffe AE; Song J; Wang G; Zhang P; Branham KE; Swaroop A; Eberhart CG; Zack DJ; Qian J; Merbs SL
    Epigenetics; 2015; 10(8):698-707. PubMed ID: 26067391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy.
    Deng Y; Qiao L; Du M; Qu C; Wan L; Li J; Huang L
    Genes Dis; 2022 Jan; 9(1):62-79. PubMed ID: 35005108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related macular degeneration.
    Cheung LK; Eaton A
    Pharmacotherapy; 2013 Aug; 33(8):838-55. PubMed ID: 23580402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
    Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT
    Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related macular degeneration – a challenge for public health care].
    Mantel I
    Ther Umsch; 2016; 73(2):79-83. PubMed ID: 26982646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related macular degeneration: a leading cause of blindness.
    O'Shea JG
    Med J Aust; 1996 Nov; 165(10):561-4. PubMed ID: 8941243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on geographic atrophy in age-related macular degeneration.
    Biarnés M; Monés J; Alonso J; Arias L
    Optom Vis Sci; 2011 Jul; 88(7):881-9. PubMed ID: 21532519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser prophylaxis for age-related macular degeneration.
    Hsu J; Maguire MG; Fine SL
    Can J Ophthalmol; 2005 Jun; 40(3):320-31. PubMed ID: 15947802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry age-related macular degeneration: A currently unmet clinical need.
    Girmens JF; Sahel JA; Marazova K
    Intractable Rare Dis Res; 2012 Aug; 1(3):103-14. PubMed ID: 25343081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related macular degeneration--a complex genetic disease].
    Antoniak K; Bienias W; Nowak JZ
    Klin Oczna; 2008; 110(4-6):211-8. PubMed ID: 18655465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.